Abstract
Purpose
To demonstrate the clinical outcomes of patients with fungal periprosthetic joint infections (PJIs) after two-stage exchange arthroplasty combined with antifungal therapy.
Methods
We retrospectively reviewed the outcomes of 41 patients with fungal PJIs after primary total knee arthroplasty (TKA) in a single centre from January 1999 to October 2017. During the first stage of resection arthroplasty, antifungal-impregnated cement spacers (AICSs) were implanted in all patients. After systemic antifungal treatment during the interval between the two surgeries, delayed reimplantation as part of a two-stage exchange protocol was performed when patients were clinically stable. We defined treatment success as a well-functioning arthroplasty without any signs of PJI after a minimum follow-up of two years without antimicrobial suppression. Successful treatment was confirmed by repeat negative cultures as well as a return of inflammatory markers to normal levels.
Results
The treatment success rate was 63.4% at the final follow-up. Thirty-six of 41 patients (87.8%) met the criteria for second-stage revision after confirmation of complete infection control. The mean prosthesis-free interval was 6.6 months (range, 2.0–30.0 months). During follow-up after two-stage exchange arthroplasty, ten patients (27.7% of 36 patients) unfortunately experienced recurrence or relapse of infection after an average of 31.3 months (range, 2.7–135.6 months). The rate of survivorship free from reinfection was 94.4% at six months, 84.8% at one year, and 73.6% at two years. Cox proportional hazard regression analysis demonstrated that the prosthesis-free interval (HR = 1.016, p = 0.037) and mean length of antifungal treatment (HR = 0.226, p = 0.046) were potential risk factors for failure.
Conclusion
Fungal PJIs led to devastating clinical outcomes despite even two-stage revision arthroplasty with the use of AICSs and antifungal medications.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
Code availability
Available from author JKS (email, seonbell@chonnam.ac.kr).
References
Emmerson KP, Moran CG, Pinder IM (1996) Survivorship analysis of the Kinematic Stabilizer total knee replacement: a 10- to 14-year follow-up. J Bone Joint Surg Br 78:441–445
Ranawat CS (2002) History of total knee replacement. J South Orthop Assoc 11:218–226
Kuzyk PR, Dhotar HS, Sternheim A, Gross AE, Safir O, Backstein D (2014) Two-stage revision arthroplasty for management of chronic periprosthetic hip and knee infection: techniques, controversies, and outcomes. J Am Acad Orthop Surg 22:153–164
Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E (2005) Epidemiology of total knee replacement in the United States Medicare population. J Bone Joint Surg Am 87:1222–1228
Azzam K, Parvizi J, Jungkind D, Hanssen A, Fehring T, Springer B et al (2009) Microbiological, clinical, and surgical features of fungal prosthetic joint infections: a multi-institutional experience. J Bone Joint Surg Am 91(Suppl 6):142–149
Phelan DM, Osmon DR, Keating MR, Hanssen AD (2002) Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature. Clin Infect Dis 34:930–938
Pulido L, Ghanem E, Joshi A, Purtill JJ, Parvizi J (2008) Periprosthetic joint infection: the incidence, timing, and predisposing factors. Clin Orthop Relat Res 466:1710–1715
Kuo FC, Goswami K, Shohat N, Blevins K, Rondon AJ, Parvizi J (2018) Two-stage exchange arthroplasty is a favorable treatment option upon diagnosis of a fungal periprosthetic joint infection. J Arthroplasty 33:3555–3560
Ueng SW, Lee CY, Hu CC, Hsieh PH, Chang Y (2013) What is the success of treatment of hip and knee candidal periprosthetic joint infection? Clin Orthop Relat Res 471:3002–3009
Nace J, Siddiqi A, Talmo CT, Chen AF (2019) Diagnosis and management of fungal periprosthetic joint infections. J Am Acad Orthop Surg 27:e804–e818
Jakobs O, Schoof B, Klatte TO, Schmidl S, Fensky F, Guenther D et al (2015) Fungal periprosthetic joint infection in total knee arthroplasty: a systematic review. Orthop Rev (Pavia) 7:5623
Schoof B, Jakobs O, Schmidl S, Klatte TO, Frommelt L, Gehrke T et al (2015) Fungal periprosthetic joint infection of the hip: a systematic review. Orthop Rev (Pavia) 7:5748
Anagnostakos K, Kelm J, Schmitt E, Jung J (2012) Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol. J Arthroplasty 27:293–298
Baecker H, Frieler S, Geßmann J, Pauly S, Schildhauer TA, Hanusrichter Y (2021) Three-stage revision arthroplasty for the treatment of fungal periprosthetic joint infection: outcome analysis of a novel treatment algorithm: a prospective study. Bone Jt Open 2:671–678
Brown TS, Petis SM, Osmon DR, Mabry TM, Berry DJ, Hanssen AD et al (2018) Periprosthetic joint infection with fungal pathogens. J Arthroplasty 33:2605–2612
Hwang BH, Yoon JY, Nam CH, Jung KA, Lee SC, Han CD et al (2012) Fungal peri-prosthetic joint infection after primary total knee replacement. J Bone Joint Surg Br 94:656–659
Kim JK, Lee DY, Kang DW, Ro DH, Lee MC, Han HS (2018) Efficacy of antifungal-impregnated cement spacer against chronic fungal periprosthetic joint infections after total knee arthroplasty. Knee 25:631–637
Merrer J, Dupont B, Nieszkowska A, De Jonghe B, Outin H (2001) Candida albicans prosthetic arthritis treated with fluconazole alone. J Infect 42:208–209
Theil C, Schmidt-Braekling T, Gosheger G, Idelevich EA, Moellenbeck B, Dieckmann R (2019) Fungal prosthetic joint infection in total hip or knee arthroplasty: a retrospective single-centre study of 26 cases. Bone Joint J 101(5):589–595
Wu MH, Hsu KY (2011) Candidal arthritis in revision knee arthroplasty successfully treated with sequential parenteral-oral fluconazole and amphotericin B-loaded cement spacer. Knee Surg Sports Traumatol Arthrosc 19:273–276
Wyman J, McGough R, Limbird R (2002) Fungal infection of a total knee prosthesis: successful treatment using articulating cement spacers and staged reimplantation. Orthopedics 25:1391–1394 discussion 1394
Fusini F, Aprato A, Massè A, Bistolfi A, Girardo M, Artiaco S (2020) Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes. Int Orthop 44:15–22
Koutserimpas C, Zervakis SG, Maraki S, Alpantaki K, Ioannidis A, Kofteridis DP et al (2019) Non-albicans Candida prosthetic joint infections: a systematic review of treatment. World J Clin Cases 7:1430–1443
Kuiper JW, van den Bekerom MP, van der Stappen J, Nolte PA, Colen S (2013) 2-stage revision recommended for treatment of fungal hip and knee prosthetic joint infections. Acta Orthop 84:517–523
Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, Della Valle CJ et al (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 469:2992–2994
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–e25
Gebauer M, Frommelt L, Achan P, Board TN, Conway J, Griffin W et al (2014) Management of fungal or atypical periprosthetic joint infections. J Arthroplasty 29:112–114
Haleem AA, Berry DJ, Hanssen AD (2004) Mid-term to long-term followup of two-stage reimplantation for infected total knee arthroplasty. Clin Orthop Relat Res. https://doi.org/10.1097/01.blo.0000147713.64235.7335-39
Sanguinetti M, Posteraro B, Lass-Flörl C (2015) Antifungal drug resistance among Candida species: mechanisms and clinical impact. Mycoses 58(Suppl 2):2–13
Yang SH, Pao JL, Hang YS (2001) Staged reimplantation of total knee arthroplasty after Candida infection. J Arthroplasty 16:529–532
Gebauer M, Frommelt L, Achan P, Board TN, Conway J, Griffin W et al (2014) Management of fungal or atypical periprosthetic joint infections. J Orthop Res 32(Suppl 1):S147–S151
Karczewski D, Ren Y, Andronic O, Akgün D, Perka C, Müller M et al (2022) Candida periprosthetic joint infections - risk factors and outcome between albicans and non-albicans strains. Int Orthop 46:449–456
Tsui C, Kong EF, Jabra-Rizk MA (2016) Pathogenesis of Candida albicans biofilm. Pathog Dis 74:ftw018
Pannanusorn S, Fernandez V, Römling U (2013) Prevalence of biofilm formation in clinical isolates of Candida species causing bloodstream infection. Mycoses 56:264–272
Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr et al (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503–535
Sidhu MS, Cooper G, Jenkins N, Jeys L, Parry M, Stevenson JD (2019) Prosthetic fungal infections: poor prognosis with bacterial co-infection. Bone Joint J 101(5):582–588
Cobo F, Rodríguez-Granger J, López EM, Jiménez G, Sampedro A, Aliaga-Martínez L et al (2017) Candida-induced prosthetic joint infection. A literature review including 72 cases and a case report. Infect Dis (Lond) 49:81–94
Acknowledgements
The authors extend their sincere thanks to Joon Kyoo Kang, MD, and Jae Hyeok Cheon, MD, for assistance with the data analysis.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by H. Y. Y., H. H. S., and J. W. K. Review, editing, and supervision by J. K. S.
Corresponding author
Ethics declarations
Ethics approval
Institutional Review Board (IRB) of Chonnam National University Hwasun Hospital approved this study (CNUHH-2022-210).
Consent to participate
For this type of study, formal consent is not required.
Consent to publish
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 22 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Yang, H.Y., Shin, H.H., Kim, J.W. et al. The fate of fungal periprosthetic joint infection after total knee arthroplasty. International Orthopaedics (SICOT) 47, 2727–2735 (2023). https://doi.org/10.1007/s00264-023-05895-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-023-05895-7